Showing 4161-4170 of 21462 results for "".
- Sustainable Advances in Myopia Treatment: Implications for Pediatric Carehttps://reachmd.com/news/sustainable-advances-in-myopia-treatment-implications-for-pediatric-care/2484441/SIU researchers report an engineered microbial route to produce 7-methylxanthine, with te
- Examining Pediatric Safety in Regional Anesthesia: Innovations and Implicationshttps://reachmd.com/news/examining-pediatric-safety-in-regional-anesthesia-innovations-and-implications/2484409/Peripheral nerve blocks did not delay the diagnosis of acute compartment syndrome in children at risk, a finding that supports continued use of regional techniques for appropriate pediatric cases to preserve analgesia without compromising timely detection.
- Innovative Reconstructive Techniques in Charcot Foot Management with 3D Bioimplantshttps://reachmd.com/news/innovative-reconstructive-techniques-in-charcot-foot-management-with-3d-bioimplants/2484413/Personalized 3D bone bioimplant reconstruction restores complex foot anatomy in athletes and active patients with Charcot neuroosteoarthropathy and offers a viable limb‑salvage option. The described
- Sperm Micro-RNAs: Pioneering New Frontiers in IVF Success Predictionhttps://reachmd.com/news/sperm-micro-rnas-pioneering-new-frontiers-in-ivf-success-prediction/2484418/A Linköping University study
- Innovations in Parkinson's Disease: Advanced Interventions and Insights into Brain Functionhttps://reachmd.com/news/innovations-in-parkinsons-disease-advanced-interventions-and-insights-into-brain-function/2484393/Researchers at UCSF have developed an AI-guided deep
- Genomic Insights: Guiding Antidepressant Selection with Precisionhttps://reachmd.com/news/genomic-insights-guiding-antidepressant-selection-with-precision/2484400/According to a new study, genetic tests using polygenic risk scores can help guide antidepressant selection for patients with depression and anxiety, offering a practical w
- Novel PCSK9 Inhibitor Recaticimab: Breaking Ground in Hyperlipidemia and Glycemic Safetyhttps://reachmd.com/news/novel-pcsk9-inhibitor-recaticimab-breaking-ground-in-hyperlipidemia-and-glycemic-safety/2484389/Recaticimab produced marked LDL‑C reductions in a randomized phase 1b/2 trial, with no glycemic signal during follow‑up, suggesting
- Unmasking the Hidden Survivors in Triple-Negative Breast Cancer: New Insights into Drug-Tolerant Persister Cellshttps://reachmd.com/news/unmasking-the-hidden-survivors-in-triple-negative-breast-cancer-new-insights-into-drug-tolerant-persister-cells/2484352/In the relentless fight against triple-negative breast cancer (TNBC), resistance to therapy remains one of the most formidable barriers to long-term remission.
- Efficacy of Benralizumab in Eosinophilic Airway Disease: Clinical Insightshttps://reachmd.com/news/efficacy-of-benralizumab-in-eosinophilic-airway-disease-clinical-insights/2484365/NATRON phase 3 update: add-on benralizumab reduced HES flares and lowered annualized flare rate in a corticosteroid-responsive hypereosinophilic syndrome cohort. According to the phase 3
- RSV: Understanding Its Impact and Laboratorial Implicationshttps://reachmd.com/news/rsv-understanding-its-impact-and-laboratorial-implications/2484386/PREPARE collaboration analysis at Singapore General Hospital finds respiratory syncytial virus (RSV) causes substantial acute severity and sh